Article Text

GW24-e1287 Atorvastatin combined with captopril treatment in hypertensive hypercholesterolemic patients
  1. Li Xiaoyan,
  2. Zhang Erhong,
  3. Zhang Ping
  1. The Third Affiliated Hospital of Sun Yat-sen University


Objectives This trial assessed the efficacy and vascular responses of combination therapy of statin with angiotensin-converting enzyme inhibitor in hypertensive hypercholesterolemic patients.

Methods This was a randomised, double-blind, placebo-controlled study of atorvastatin alone, captopril alone and atorvastatin combined with captopril in 95 hypertensive hypercholesterolemic patients for 2 months with 2 months washout.

Results Captopril alone did not significantly change C-reactive protein levels and lipoproteins, however, atorvastatin and atorvastatin combined with captopril significantly changed those, and atorvastatin combined with captopril showed significantly more improvement than captopril alone (P < 0.01, respectively).Atorvastatin, captopril and atorvastatin combined with captopril all could improved the percent flow-mediated dilator response to hyperemia (6.9 ± 0.7 vs 6.2 ± 0.3 vs 10.2 ± 0.5, P < 0.01); reduced plasma levels of malondialdehyde (umol/L) (1.9 ± 0.1vs 1.6 ± 0.2 vs 0.8 ± 0.01,P < 0.01), monocyte chemoattractant protein-1 (pg/mL) (179 ± 6 vs 167 ± 8 vs 127 ± 3,P < 0.01) and plasminogen activator inhibitor-1 antigen (ng/mL) (68 ± 2 vs 70 ± 5 vs 43 ± 6,P < 0.01), and the effect of atorvastatin combined with captopril was more than captopril alone or atorvastatin alone (P < 0.01, respectively).

Conclusions Atorvastatin combined with captopril significantly improves endothelial function and reduces inflammatory markers in hypertensive hypercholesterolemic patients.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.